神韻治療公司
US ˙ NasdaqGS ˙ US92539P1012
該符號不再有效

SecurityVERV / Verve Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership122,383 shares
Latest Disclosed Value $ 1,374,361
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in VERV / Verve Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 122,383 shares of Verve Therapeutics, Inc. (US:VERV) valued at $1,374,361 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 122,383 shares of Verve Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,362,123 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Verve Therapeutics EC US92539P1012 122,383 0 0.00 1,374 145.80 0.0309
2025-05-28 2025-03-31 NP Verve Therapeutics EC US92539P1012 122,383 0 0.00 559 -18.99 0.0134
2025-02-25 2024-12-31 NP Verve Therapeutics EC US92539P1012 122,383 -19,264 -13.60 690 0.73 0.0151
2024-11-26 2024-09-30 NP Verve Therapeutics EC US92539P1012 141,647 18,847 15.35 686 14.36 0.0130
2024-08-26 2024-06-30 NP Verve Therapeutics EC US92539P1012 122,800 7,331 6.35 599 -60.93 0.0122
2024-05-28 2024-03-31 NP Verve Therapeutics EC US92539P1012 115,469 21,621 23.04 1,533 17.20 0.0320
2024-02-26 2023-12-31 NP Verve Therapeutics EC US92539P1012 93,848 9,369 11.09 1,308 16.79 0.0279
2023-11-28 2023-09-30 NP Verve Therapeutics EC US92539P1012 84,479 -3,473 -3.95 1,120 -32.08 0.0292
2023-08-25 2023-06-30 NP Verve Therapeutics EC US92539P1012 87,952 13,387 17.95 1,649 53.40 0.0391
2023-05-26 2023-03-31 NP Verve Therapeutics EC US92539P1012 74,565 3,049 4.26 1,075 -22.27 0.0286
2023-02-24 2022-12-31 NP Verve Therapeutics EC US92539P1012 71,516 -542 -0.75 1,384 -44.12 0.0381
2022-11-25 2022-09-30 NP Verve Therapeutics EC US92539P1012 72,058 14,721 25.67 2,475 182.53 0.0709
2022-08-25 2022-06-30 NP Verve Therapeutics EC US92539P1012 57,337 2,482 4.52 876 -29.98 0.0242
2022-05-26 2022-03-31 NP Verve Therapeutics EC US92539P1012 54,855 30,797 128.01 1,252 41.04 0.0292
2022-02-25 2021-12-31 NP Verve Therapeutics EC US92539P1012 24,058 0 0.00 887 -21.50 0.0192
2021-11-24 2021-09-30 NP Verve Therapeutics EC US92539P1012 24,058 24,058 1,131 0.0249
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.